Marshall Wace’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Marshall Wace's CLB Position: Q1 2026 in Review
Marshall Wace opened a new position in Core Laboratories (CLB) in Q1 2026: 117,744 shares worth $1.98M. The stake represents ﹤0.01% of the portfolio and ranks #1795 among its holdings. This is a return to the name: Marshall Wace previously reported a position in CLB as recently as Q4 2024.
Marshall Wace first reported a position in CLB in Q1 2016 and has held it in 16 quarters since. The position peaked at $25.7M in Q2 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Marshall Wace held 117,744 shares of Core Laboratories worth $1.98M as of Q1 2026.
- Core Laboratories was a new Marshall Wace position in Q1 2026.
- Core Laboratories made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1795 holding.
- Marshall Wace first reported a position in Core Laboratories in Q1 2016 and has held it in 16 quarters since.
- Marshall Wace's Core Laboratories position peaked at $25.7M in Q2 2016.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.